These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37563933)

  • 1. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
    Dvorak V; Superti-Furga G
    Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A substrate-based ontology for human solute carriers.
    Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G
    Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.
    Dvorak V; Wiedmer T; Ingles-Prieto A; Altermatt P; Batoulis H; Bärenz F; Bender E; Digles D; Dürrenberger F; Heitman LH; IJzerman AP; Kell DB; Kickinger S; Körzö D; Leippe P; Licher T; Manolova V; Rizzetto R; Sassone F; Scarabottolo L; Schlessinger A; Schneider V; Sijben HJ; Steck AL; Sundström H; Tremolada S; Wilhelm M; Wright Muelas M; Zindel D; Steppan CM; Superti-Furga G
    Front Pharmacol; 2021; 12():722889. PubMed ID: 34447313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
    Tu G; Fu T; Zheng G; Xu B; Gou R; Luo D; Wang P; Xue W
    J Chem Inf Model; 2024 Mar; 64(5):1433-1455. PubMed ID: 38294194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Druggability of Solute Carriers.
    Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
    J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily.
    Digles D; Ingles-Prieto A; Dvorak V; Mocking TAM; Goldmann U; Garofoli A; Homan EJ; Di Silvio A; Azzollini L; Sassone F; Fogazza M; Bärenz F; Pommereau A; Zuschlag Y; Ooms JF; Tranberg-Jensen J; Hansen JS; Stanka J; Sijben HJ; Batoulis H; Bender E; Martini R; IJzerman AP; Sauer DB; Heitman LH; Manolova V; Reinhardt J; Ehrmann A; Leippe P; Ecker GF; Huber KVM; Licher T; Scarabottolo L; Wiedmer T; Superti-Furga G
    Front Pharmacol; 2024; 15():1401599. PubMed ID: 39050757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in ligands and chemical probes targeting solute carrier transporters.
    Casiraghi A; Bensimon A; Superti-Furga G
    Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural biology of solute carrier (SLC) membrane transport proteins.
    Bai X; Moraes TF; Reithmeier RAF
    Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
    Ceder MM; Fredriksson R
    Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species.
    Höglund PJ; Nordström KJ; Schiöth HB; Fredriksson R
    Mol Biol Evol; 2011 Apr; 28(4):1531-41. PubMed ID: 21186191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solute carrier transporters and the brain: Physiological and pharmacological implications.
    Hu C; Tao L; Cao X; Chen L
    Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
    Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solute carriers as drug targets: current use, clinical trials and prospective.
    Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB
    Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus.
    Le J; Chen Y; Yang W; Chen L; Ye J
    Acta Pharm Sin B; 2024 Feb; 14(2):437-454. PubMed ID: 38322335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining solute carrier transporter signatures of murine immune cell subsets.
    Aaes TL; Burgoa Cardás J; Ravichandran KS
    Front Immunol; 2023; 14():1276196. PubMed ID: 38077407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances on the inhibition of human solute carriers: Therapeutic implications and mechanistic insights.
    Wright NJ; Lee SY
    Curr Opin Struct Biol; 2022 Jun; 74():102378. PubMed ID: 35487145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors.
    Dvorak V; Casiraghi A; Colas C; Koren A; Tomek T; Offensperger F; Rukavina A; Tin G; Hahn E; Dobner S; Frommelt F; Boeszoermenyi A; Bernada V; Hannich JT; Ecker GF; Winter GE; Kubicek S; Superti-Furga G
    Cell Chem Biol; 2023 Aug; 30(8):953-964.e9. PubMed ID: 37516113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.